EQUITY-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Fair Value Assumptions

The fair value of the option grants

awarded during the six - month period ended June 30, 2024 was $0.1 million, which has been estimated with the following assumptions on the grant date.

	Six Months Ended June 30
	2024
Risk-free interest rate	4.25%-4.61%
Volatility	106.07% - 123.31%
Expected life (years)	5.00-6.00
Expected dividend yield	0%

Schedule of Stock Option Activity

The following table summarizes stock option activity for employees and non-employees for the six months ended June 30, 2024 and 2023:

	Shares	Weighted-Average Exercise Price		Weighted-Average Remaining Contractual Term (in years)
Outstanding at December 31, 2022	13,391	$	189.36	8.29
Granted	—
Exercised	—
Forfeited	—
Expired	—
Outstanding at June 30, 2023	13,391	$	189.36	8.04
Exercisable at June 30, 2023	7,484	$	226.40	7.83
Outstanding at December 31, 2023	11,164	$	190.24	7.26
Granted	21,125	$	3.02
Exercised	—
Forfeited	735
Expired	—
Outstanding at June 30, 2024	31,554	$	66.75	8.71
Exercisable at June 30, 2024	8,692	$	209.91	6.64